Board of Directors

Chairman of the Company's Board of Directors. Responsible for Commercial, International and Governmental Affairs since November 1, 2017. Chemical engineer, qualified economic engineer. With Richter since 1970 in a number of Research and Development management positions. Medimpex director in Mexico from 1977 to 1983. Managing Director of Medimpex UK from 1988 to 1992. Member of the Board of MAGYOSZ, Chairman between 2006 and 2016.  Chief Executive Officer of Gedeon Richter from 1992 to November 2017.

Appointed Chief Executive Officer from November 1, 2017. Began his professional career as an economist for the National Bank of Hungary and the European Central Bank. He later joined Aegon Asset Management where he worked as a fund manager and the head of the fixed income desk. He served as the state secretary in charge of taxation and the financial sector at the Minisrty for National Economy for two and a half years, followed by a year spent at Banque Rothschild where he worked as a consultant. He earned is MA degree at the Budapest University of Economics and studied also in the United States. Richter's Director of Corporate Strategy since September 2016, Chief Operating Officer since 2017. Member of the Company's Board of Directors from April 2017.

Appointed Deputy Managing Director upon joining the Company in 2000. Responsible for Finance. Economist, University doctorate in Economic Sciences. Previously General Secretary of State, Ministry of Economic Affairs.​

​Economist, sociologist, management and strategic consultant. Ambassador of Hungary to the UK between 2011 and 2014.  Previously member of the board of directors and advisory boards of several companies (MOL- Hungarian Oil and Gas Co., Westel - now T-Mobile, Matáv - now Magyar Telekom, CA-IB Investment Bank). Mr Csák is a trustee in a number of NGOs and lecturer in social sciences. In 2009-10 he was a visiting fellow in political economy at The Heritage Foundation in Washington DC. Joined Richter's Board of Directors in April 2014.

Lawyer, securities specialist. Began her professional career at Hungarian State Development Bank. Between 1988 and 1990 Head of Securities Trading Secretariat (the predecessor of Budapest Stock Exchange). Between 1990 and 1992 founder CEO of the Budapest Stock Exchange and member of its Board. From 1992 to 1994 Board Member of Hungarian State Property Agency, Privatization Agencies (ÁVÜ, ÁPV). From 1994 to 2004 she worked as attorney at law. Besides she held numerous positions (member of the Central Bank Council of Hungarian National Bank, Chairperson of the Pension Fund Asset Management Co. – National Social Security, member of the Monetary Council of Hungarian National Bank, Chairperson of the Hungarian Investor's Protection Fund). Currently Chairperson of the Board „Aranykor" Voluntary Pension Fund, member of the Budapest Stock Exchange Advisory Committee, chair of the Supervisory Board of BOM, deputy chair of the Hungarian Atlantic Council, Board member of ÖPOSZ.  Member of the Company's Board of Directors since April 26, 2017.

Professor of pharmacology and toxicology, Pharm. D., PhD at Semmelweis University, DSc at the Hungarian Academy of Sciences (MTA). Fogarty Visiting Fellow at the Section on Clinical Neuropharmacology, Laboratory of Clinical Science, National Institute of Mental Health (NIMH) / Bethesda, USA/ between 1986 and 89, then research consultant at the Clinical Neuroendocrinology Branch of NIMH for two years. Senior research fellow and Head of Laboratory from 1993, scientific director between 2002 and 2007 at the National Institute of Psychiatry and Neurology, Hungary. Research professor of the Department of Pharmacology and Pharmacotherapy at the Faculty of Medicine of Semmelweis University in 2007 and 2008. Head of Department of Pharmacodynamics at the Faculty of Pharmacy, Semmelweis University since 2008. Simultaneously, vice rector for scientific affairs at Semmelweis University between 2015 and 2018. Supervisor in numerous Doctoral Schools. Two of his supervised PhD students were granted the Bólyai Research Fellowship, and three of them received the Junior Prima Award in category of science. Member of the Academia Europaea and Board member of the Society of Hungarian Psychopharmacologists, and the Hungarian Society for Experimental and Clinical Pharmacology. Member of three Committees of the Hungarian Academy of Sciences, and formerly, the Expert Committee on Medical Sciences of the Hungarian Accreditation Committee, and the Jury of the Hungarian Research Fund (OTKA). Editorial Board member of highly ranked national and international scientific journals. In 2012 he received the Academy award of the Hungarian Academy of Sciences and in 2014 he was granted by Issekutz Award.

Economist and sociologist. Employee of Budapest Bank from 1987, later employee of Creditanstalt Group. At the end of 1990’s leader of CA-IB, then from 2000 to 2007 deputy CEO and member of the Board of Directors of OTP Bank Nyrt. Currently member,  chairman of the Board of Directors of and of the Supervisory Board of several Hungarian and international companies. Joined the Board of Richter in 2010.​

Economist, PhD candidate of Budapesti Corvinus University on field of strategic management. From 1998 to 2001 consultant at IFUA Horváth & Partner Ltd. In first quarter of 2001 worked as senior consultant, BPR – project leader at Debis IT Services Ltd.. From April, 2001 to 2005 she is Strategic Coordination Director at Magyar Posta Rt. From 2015 Chief Executive Officer and Chairman of the Board of Directors of Hungarian Post Insurance Co. (Magyar Posta Biztosító Zrt.) and Hungarian Post Life Insurance Co. (Magyar Posta Életbiztosító Zrt.). Since 2009 Executive Board Member of the Association of Hungarian Insurance Companies, Association's Deputy President between 2010 and 2013, from 2013 its President. Member, later President of the Supervisory Board of Bolyai Workshop Foundation. Member of the Editorial Board of the Financial and Economic Review (Hitelintézeti Szemle), founding President of the Editorial Board of professional review named "Insurance and Risk" (Biztosítás és Kockázat). Member of Gedeon Richter Plc's Board of Directors since April, 2018.

​Economist, graduated at the Budapesti University of Economics, Faculty of Finance. Between 1998 and 2000 futures trader, then FX trader. Since 2000 Employed by Equilor Investment Ltd. Corporate Finance Director from 2002 to 2004, Managing Director between 2005 and 2009. Since 2010 Chief Executive Officer at Equilor Investment Ltd. Parallel with his employment Chairman of the Supervisory Board at Equilor Asset Management Ltd. and Chief Executive Officer of Central-Eastern European Private Equity and Venture Capital Management Ltd. In scope of his social engagement member of the advisory board at Foundation of the Faculty of Corporate Finance at Budapesti Corvinus University, and vice-president of Budapest Stock Exchange between 2011 and 2015. Member of Gedeon Richter Plc's Board of Directors since April, 2018.

Medical doctor, academician. Graduated from Semmelweis University of Medicine. From 1989 to 2002 Director of the Institute of Experimental Medicine (IEM) of the Hungarian Academy of Sciences. President of the Hungarian Academy of Sciences between 2002 and 2008. Currently a researcher at the IEM. Joined the Board in 2008.​

​MSc in Pharmacy, Doctor of Pharmacy, international marketing expert. From 1992 to 2002 worked at Roche Magyarország Kft. as a medical representative and coordinated clinical trials as a biotechnological product specialist. Since 2002 is the owner and managing director of one of Hungary's largest pharmacies, Szeged's Kígyó Pharmacy. Since 2015 managing director of Gedeon Richter UK Ltd. and Medimpex UK Ltd. headquartered in London. Joined the Board in April 2014.